InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,442.06
(
0.19%
)
US TECH 100
19,230.40
(
0.33%
)
Dow Jones
38,599.01
(
0.03%
)
Brent Oil
83.03
(
1.10%
)
Bitcoin
65,440.37
(
-1.80%
)
Post# of 252220
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

vinmantoo

Send PM Follow Ignore
Followers 30
Posts 4124
Boards Moderated 0
Alias Born 07/25/2007

vinmantoo

Re: Mufaso post# 250781

Tuesday, 02/27/2024 11:41:37 AM

Tuesday, February 27, 2024 11:41:37 AM

Post# of 252220

The data provided so far shows VK2735 to be both more efficacious and more tolerable than tirzepatide. It was a home run especially on tolerability given the aggressive dosing/titration. Comments by analysts in the conference call included: "Looks more potent than Zepbound" "Stellar" and "Pristine profile".



Mufaso, you are the man. Congratulations on VKTX!! After reading your comments I bought a little and was planning on doing a bit more research before buying more but I was slow. Thanks so much and I look forward to hearing your analysis of the CC.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up